Fol. Biol. 2023, 69, 181-185

https://doi.org/10.14712/fb2023069050181

CD14 Polymorphism Is Not Associated with SARS-CoV-2 Infection in Central European Population

Jaroslav A. Hubáček1,2, Tom Philipp3, Ondřej Májek4,5, Dana Dlouhá2, Věra Adámková6, Ladislav Dušek4,5

1Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
2Third Department of Medicine, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University, Prague, Czech Republic
3Clinic of Rheumatology and Physiotherapy, Third Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
4Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
5Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic
6Preventive Cardiology Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

Received December 2023
Accepted January 2024

References

1. Al Balushi, A., AlShekaili, J., Al Kindi, M. et al. (2021) Immunological predictors of disease severity in patients with COVID-19. Int. J. Infect. Dis. 110, 83-92. <https://doi.org/10.1016/j.ijid.2021.06.056>
2. Bowman, E. R., Cameron, C. M. A., Avery, A. et al. (2021) Levels of soluble CD14 and tumor necrosis factor receptors 1 and 2 may be predictive of death in severe coronavirus disease 2019. J. Infect. Dis. 223, 805-810. <https://doi.org/10.1093/infdis/jiaa744>
3. Chams, N., Chams, S., Badran, R. et al. (2020) COVID-19: a multidisciplinary review. Front. Public Health 8, 383. <https://doi.org/10.3389/fpubh.2020.00383>
4. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020) The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536-544.
5. Delanghe, J. R., Speeckaert, M. M. (2022) Host polymorphisms and COVID-19 infection. Adv. Clin. Chem. 107, 41-77. <https://doi.org/10.1016/bs.acc.2021.07.002>
6. Hubacek, J. A., Skodova, Z., Adamkova, V. et al. (2004) Association of the −159C → T polymorphism in the CD14 promoter with variations in serum lipoproteins in healthy subjects. Blood Coagul. Fibrinolysis 15, 365-366. <https://doi.org/10.1097/00001721-200406000-00013>
7. Hubacek, J. A., Rothe, G., Piťha, J. et al. (1999) C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99, 3218-3220. Erratum in: Circulation 100, 2550. <https://doi.org/10.1161/01.CIR.99.25.3218>
8. Hubacek, J. A. (2021a) Effects of selected inherited factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression. Physiol. Res. 70(S2), S125-S134. <https://doi.org/10.33549/physiolres.934730>
9. Hubacek, J. A., Dusek, L., Majek, O. et al. (2021b) CCR5Δ32 deletion as a protective factor in Czech first-wave COVID-19 subjects. Physiol. Res. 70, 111-115. <https://doi.org/10.33549/physiolres.934647>
10. Hubacek, J. A., Dusek, L., Majek, O. et al. (2021c) ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors. Clin. Chim. Acta 519, 206-209. <https://doi.org/10.1016/j.cca.2021.04.024>
11. Hubacek, J. A., Philipp, T., Adamkova, V. et al. (2023a) ABCA3 and LZTFL1 polymorphisms and risk of COVID-19 in the Czech population. Physiol. Res. 72, 539-543. <https://doi.org/10.33549/physiolres.935108>
12. Hubacek, J. A., Philipp, T., Adamkova, V. et al. (2023b) A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population. Clin. Chim. Acta 538, 211-215. <https://doi.org/10.1016/j.cca.2022.12.025>
13. Kostrouch, Z. (2020) Beyond genomes and the Covid-19 pandemic. Folia Biol. (Praha) 66, 85. <https://doi.org/10.14712/fb2020066030085>
14. Long, H., Zhao, J., Zeng, H. L. et al. (2021) Prolonged viral shedding of SARS-CoV-2 and related factors in symptomatic COVID-19 patients: a prospective study. BMC Infect. Dis. 21, 1282. <https://doi.org/10.1186/s12879-021-07002-w>
15. Nayeri, N. D., Nadali, J., Divani, A. et al. (2021) Clinical manifestation, laboratory and radiology finding, treatment and outcomes of COVID-19: a systematic review and meta-analysis. J. Res. Med. Sci. 26, 41.
16. Paces, J., Strizova, Z., Smrz, D. et al. (2020) COVID-19 and the immune system. Physiol. Res. 69, 379-388. <https://doi.org/10.33549/physiolres.934492>
17. Panda, A. K., Tripathy, R., Das, B. K. (2020) CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: a hospital-based case-control study. Lupus 30, 219-227. <https://doi.org/10.1177/0961203320972799>
18. Pati, A., Padhi, S., Panda, D. et al. (2021) A cluster of differentiation 14 (CD14) polymorphism (C-159T rs2569190) is associated with SARS-CoV-2 infection and mortality in the European population. J. Infect. Dis. 224, 921-922. <https://doi.org/10.1093/infdis/jiab180>
19. Severe Covid-19 GWAS Group, Ellinghaus, D., Degenhardt, F. et al. (2020) Genomewide association study of severe COVID-19 with respiratory failure. N. Engl. J. Med. 383, 1522-1534.
20. Tai, D. B. G., Shah, A., Doubeni, C. A. et al. (2021) The disproportionate impact of COVID-19 on racial and ethnic minorities in the United States. Clin. Infect. Dis. 72, 703-706. <https://doi.org/10.1093/cid/ciaa815>
21. Tuček, M., Vaněček, V. (2022) COVID-19 in the Czech Republic 2020 and 2021: comparative analysis of probable work-related transmission of the coronavirus SARS-CoV-2. Cent. Eur. J. Public Health 30, 201-204. <https://doi.org/10.21101/cejph.a7610>
22. Viza, D., Pizza, G., De Vinci, C. et al. (2020) Transfer factor as an option for managing the COVID-19 pandemic. Folia Biol. (Praha) 66, 86-90. <https://doi.org/10.14712/fb2020066030086>
23. Yuan, F. F., Boehm, I., Chan, P. K. et al. (2007) High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus. Clin. Vaccine Immunol. 14, 1644-1645. <https://doi.org/10.1128/CVI.00100-07>
24. Zhu, J., Wu, C., Wu, L. (2021) Associations between genetically predicted protein levels and COVID-19 severity. J. Infect. Dis. 223, 19-22. <https://doi.org/10.1093/infdis/jiaa660>
25. Zingaropoli, M. A., Nijhawan, P., Carraro, A. (2021) Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia. Front. Immunol. 12, 627548. <https://doi.org/10.3389/fimmu.2021.627548>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive